pocketful logo light
pocketful logo light
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

NSE: DRREDDY BSE: 500124

1214.80

(0.30%)

Wed, 29 Jul 2026, 11:08 pm

Dr Reddys Laboratories Share Price Live Chart

1 Day

(0.30%)

No Result Found

Summary

  • Market Cap (in Cr)

    108751.63

  • Net Profit (in Cr)

    5725.2

  • P/B

    2.84

  • Sector P/E

    33.76

  • P/E

    16.87

  • EV/EBITDA

    10.10

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    17.01

  • ROCE (Industry)

    16.41

  • RONW (Industry)

    14.52

  • ROE

    18.53

  • ROCE

    23.05

  • Debt/Equity

    0.11

  • EPS (TTM)

    50.27

  • Dividend Yield

    0.61

  • Book Value

    453.98

  • Interest Cover

    28.15

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters26.6326.6426.6426.6426.64
FII21.1422.3424.6925.3225.75
DII30.7230.4427.9826.7425.62
Public21.5020.5920.6921.3021.99
Government00000

Read More

Technical Analysis

RSI

26.19

MACD

-42.49

50 DMA

1276.47

200 DMA

1262.24

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1673.131506.631431.871340.131265.371173.631007.13
Fibonacci1506.631443.031403.741340.131276.531237.241173.63
Camarilla1402.891387.631372.361340.131341.841326.571311.31

Pivots Level: Classic

R3

+333

1673.13

R2

+166.50

1506.63

R1

+91.73

1431.87

1340.13
1340.13
Pivot Point
LTP: 1142.30

S1

-74.77

1265.37

S2

-166.50

1173.63

S3

-333

1007.13

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1178.49

  • 20-EMA

    1216.39

  • 30-EMA

    1237.19

  • 50-EMA

    1256.07

  • 100-EMA

    1266.54

  • 200-EMA

    1265.03

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 May 2026agm
12 May 2026board-meetingsAccounts, Quarterly Results
21 Jan 2026board-meetingsQuarterly Results
10 Jun 2025dividendFinal Dividend - Rs. - 810 Jul 2025
09 May 2025dividend₹8.00 Dividend /Share10 Jul 2025
09 May 2025agm
28 Sept 2024dividendFace Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share28 Oct 2024
28 Sept 2024splitStock Split From Rs.5 to Rs.128 Oct 2024
27 Jul 2024split1:5 Splits of Equity Shares28 Oct 2024
16 Jun 2024dividendAnnual General Meeting/Dividend - Rs 40 Per Share17 Jul 2024

Read More

Peer Comparison

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Dr Reddys Laboratories Ltd About

Dr Reddys Laboratories offers a portfolio of products and services including active pharmaceutical ingredients (“APIs”), generics, branded generics, biosimilars, over the counter (“OTC”) products and pharmaceutical services.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1984

Headquarters

CEO

K Satish Reddy

Employees

Contact

Website icon

Website

http://www.drreddys.com

Email icon

Email

shares@drreddys.com; mail@drreddys.com

Phone icon

Phone

91-40-49002900

Location icon

Location

8-2-337 Road No 3, Banjara Hills, Hyderabad, Telangana, 500034

Read More

Dr Reddys Laboratories Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
KAPITALFORENINGEN INVESTIN PROblockBuy5812681250.609 Sept 2025
KAPITALFORENINGEN PENSAM INVESTblockSell5812681250.609 Sept 2025
THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849blockBuy141606125414 Jul 2025
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828blockSell141606125414 Jul 2025
BOFA SECURITIES EUROPE SAblockBuy2600006184.8526 Mar 2024
BOFA SECURITIES EUROPE SAblockSell2600006184.8526 Mar 2024
THE JUPITER GLOBAL FUND-JUPITER INDIA SELECTblockBuy319075645.4518 Jan 2024
JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITEDblockSell319075645.4518 Jan 2024
AIA INVESTMENT TRUST AIA SINGAPORE PARTCIPATING FUND HERITAGE SGDblockSell4285355.226 Oct 2023
AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND USDblockSell15515355.226 Oct 2023

Read More

Dr Reddys Laboratories Ltd News

Dr Reddys AGM: Dividend, Auditors & Directors Approved

Dr Reddys Laboratories shareholders approved a ₹8 dividend and re-appointed key directors at its 42nd AGM on July 23, 2026. Deloitte was named statutory auditor for five years.

23 Jul 2026

companies

Dr Reddy's Q1FY27 revenue dips 6% to ₹8,071 Cr

Dr Reddy's Laboratories reported a 6% YoY decline in Q1FY27 revenue to ₹8,071 Cr, impacted by semaglutide API costs. EBITDA fell 56% to ₹1,009 Cr, while PAT dropped 69% to ₹443 Cr.

22 Jul 2026

companies

Dr Reddy's Q1FY27 net profit falls 69%

Dr Reddy's Laboratories reported a 69% YoY decline in Q1FY27 net profit to ₹4,435 million, impacted by a ₹2,397 million provision for semaglutide API issues. Revenue fell 5.6% YoY to ₹80,705 million.

22 Jul 2026

companies

Dr Reddy's sets Q1FY27 results date

Dr Reddy's Laboratories will announce Q1FY27 results on July 22, 2026, followed by an earnings call at 19:30 IST.

13 Jul 2026

companies

Dr Reddy's delays semaglutide supplies

Dr Reddy's Laboratories Ltd reported API issues delaying semaglutide commercial supplies. An analyst call is scheduled for July 9, 2026.

09 Jul 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number